Antibody cocktail to prevent and treat COVID-19 enters late-stage trials
When you buy through links on our land site , we may earn an affiliate charge . Here ’s how it works . An antibody cocktail plan to foreclose and care for COVID-19 is now entering tardy - point clinical trial , according to story . When naturally infected with COVID-19 , the trunk render Y - shaped molecules call antibodies that latch onto the virus and mark it for destruction , or hinder its power to taint level-headed cells , Live Science antecedently reported ....